BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 16475970)

  • 1. A collaborative hit-to-lead investigation leveraging medicinal chemistry expertise with high throughput library design, synthesis and purification capabilities.
    Yang X; Parker D; Whitehead L; Ryder NS; Weidmann B; Stabile-Harris M; Kizer D; McKinnon M; Smellie A; Powers D
    Comb Chem High Throughput Screen; 2006 Feb; 9(2):123-30. PubMed ID: 16475970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraction of structure-activity relationship information from high-throughput screening data.
    Wawer M; Bajorath J
    Curr Med Chem; 2009; 16(31):4049-57. PubMed ID: 19754425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An informatic pipeline for managing high-throughput screening experiments and analyzing data from stereochemically diverse libraries.
    Mulrooney CA; Lahr DL; Quintin MJ; Youngsaye W; Moccia D; Asiedu JK; Mulligan EL; Akella LB; Marcaurelle LA; Montgomery P; Bittker JA; Clemons PA; Brudz S; Dandapani S; Duvall JR; Tolliday NJ; De Souza A
    J Comput Aided Mol Des; 2013 May; 27(5):455-68. PubMed ID: 23585218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combinatorial synthesis: an important methodology in medicinal chemistry].
    Seoane Prado C
    An R Acad Nac Med (Madr); 2005; 122(4):723-37; discussion 737-40. PubMed ID: 16776324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key aspects of the Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection.
    Jacoby E; Schuffenhauer A; Popov M; Azzaoui K; Havill B; Schopfer U; Engeloch C; Stanek J; Acklin P; Rigollier P; Stoll F; Koch G; Meier P; Orain D; Giger R; Hinrichs J; Malagu K; Zimmermann J; Roth HJ
    Curr Top Med Chem; 2005; 5(4):397-411. PubMed ID: 15892682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of chemical space for collaborative lead generation and drug discovery: the European Lead Factory Perspective.
    Karawajczyk A; Giordanetto F; Benningshof J; Hamza D; Kalliokoski T; Pouwer K; Morgentin R; Nelson A; Müller G; Piechot A; Tzalis D
    Drug Discov Today; 2015 Nov; 20(11):1310-6. PubMed ID: 26429298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Analysis of Different Components of a High-Throughput Screening Library.
    Saha A; Varghese T; Liu A; Allen SJ; Mirzadegan T; Hack MD
    J Chem Inf Model; 2018 Oct; 58(10):2057-2068. PubMed ID: 30204440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current practices in generation of small molecule new leads.
    Goodnow RA
    J Cell Biochem Suppl; 2001; Suppl 37():13-21. PubMed ID: 11842423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
    Sukuru SC; Jenkins JL; Beckwith RE; Scheiber J; Bender A; Mikhailov D; Davies JW; Glick M
    J Biomol Screen; 2009 Jul; 14(6):690-9. PubMed ID: 19531667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.
    Ghose AK; Viswanadhan VN; Wendoloski JJ
    J Comb Chem; 1999 Jan; 1(1):55-68. PubMed ID: 10746014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application and utilization of chemoinformatics tools in lead generation and optimization.
    Fotouhi N; Gillespie P; Goodnow RA; So SS; Han Y; Babiss LE
    Comb Chem High Throughput Screen; 2006 Feb; 9(2):95-102. PubMed ID: 16475967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology.
    Kéri G; Székelyhidi Z; Bánhegyi P; Varga Z; Hegymegi-Barakonyi B; Szántai-Kis C; Hafenbradl D; Klebl B; Muller G; Ullrich A; Erös D; Horváth Z; Greff Z; Marosfalvi J; Pató J; Szabadkai I; Szilágyi I; Szegedi Z; Varga I; Wáczek F; Orfi L
    Assay Drug Dev Technol; 2005 Oct; 3(5):543-51. PubMed ID: 16305311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening].
    Schirlin D; Galvan M; Le Fur G
    Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Industrial medicinal chemistry insights: neuroscience hit generation at Janssen.
    Tresadern G; Rombouts FJR; Oehlrich D; Macdonald G; Trabanco AA
    Drug Discov Today; 2017 Oct; 22(10):1478-1488. PubMed ID: 28669605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in focused library design: targeting gene-families.
    Miller JL
    Curr Top Med Chem; 2006; 6(1):19-29. PubMed ID: 16454755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarity searching and scaffold hopping in synthetically accessible combinatorial chemistry spaces.
    Boehm M; Wu TY; Claussen H; Lemmen C
    J Med Chem; 2008 Apr; 51(8):2468-80. PubMed ID: 18380426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current directions in the evolution of compound libraries.
    Webb TR
    Curr Opin Drug Discov Devel; 2005 May; 8(3):303-8. PubMed ID: 15892244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a compound screening collection for use in high throughput screening.
    Harper G; Pickett SD; Green DV
    Comb Chem High Throughput Screen; 2004 Feb; 7(1):63-70. PubMed ID: 14965262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of small molecule libraries for NMR screening and other applications in drug discovery.
    Jacoby E; Davies J; Blommers MJ
    Curr Top Med Chem; 2003; 3(1):11-23. PubMed ID: 12570776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.